Prodromal Alzheimer's Disease Clinical Trials

24 clinical trials for Prodromal Alzheimer's Disease across international registries, including 5 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• A Study to Assess the Effects of ACI-24.060 in Alzheimer's Disease and in Down Syndrome (ABATE Study) — RECRUITING · PHASE1
• Alzheimer's Tau Platform: Master Protocol — RECRUITING · PHASE2
• Alzheimer's Tau Platform: Regimen A - AADvac1 — RECRUITING · PHASE2
• The Digital Memory Notebook — RECRUITING · NA
• Exploring the Gut-Brain Axis in Ageing and Neurodegeneration — RECRUITING
• A Safety and Efficacy Study for Alzheimer's Disease (Prodromal AD) — TERMINATED · PHASE3
• Combined tDCS and Cognitive Training in Alzheimer's — COMPLETED · NA
• Partnered Rhythmic Rehabilitation in Prodromal Alzheimer's Disease — COMPLETED · NA
• Financial Incentives and Recruitment to the APT Webstudy — COMPLETED · NA
• Clinical Trial of AGB101 for Mild Cognitive Impairment — WITHDRAWN · PHASE2
• Deferiprone to Delay Dementia (The 3D Study) — COMPLETED · PHASE2
• TRC-PAD Program: In-Clinic Trial-Ready Cohort — COMPLETED
• Amyloid Prediction in Early Stage Alzheimer's Disease From Acoustic and Linguistic Patterns of Speech - FUTURE Extension — TERMINATED
• Amyloid Prediction in Early Stage Alzheimer's Disease Through Speech Phenotyping - FUTURE Extension — TERMINATED
• Study of AGB101 in Mild Cognitive Impairment Due to Alzheimer's Disease — COMPLETED · PHASE2
• Brain Iron Toxicity and Neurodegeneration - A 7T MRI Study — OTHER
• Hyperbaric Oxygen Therapy for Prodromal Alzheimer´s Disease With Cerebrovascular Disease — OTHER · NA
• COGNIFOOD-Changing the Carbohydrate/Fat-ratio to Prevent Cognitive Decline and Alzheimer Pathology: A Pilot Study — OTHER · NA
• Amyloid Prediction in Early Stage Alzheimer's Disease From Acoustic and Linguistic Patterns of Speech - PAST Extension — OTHER
• Amyloid Prediction in Early Stage Alzheimer's Disease Through Speech Phenotyping - PAST Extension — OTHER
• Amyloid Prediction in Early Stage Alzheimer's Disease Through Speech Phenotyping — COMPLETED
• Amyloid Prediction in Early Stage Alzheimer's Disease From Acoustic and Linguistic Patterns of Speech — COMPLETED
• Efficacy and Safety Trial of Verubecestat (MK-8931) in Participants With Prodromal Alzheimer's Disease (MK-8931-019) — TERMINATED · PHASE3
• An Open-Label Study Investigating MK-8931 in Participants With Mild and Moderate Hepatic Insufficiency (MK-8931-016) — COMPLETED · PHASE1

Refine this search